BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32956108)

  • 1. Penile Metastasis From Prostate Cancer Detected by 18F-Fluorocholine PET/CT.
    Bianchi D; Rizzo A; Bonacina M; Zaniboni A; Savelli G
    Clin Nucl Med; 2021 Jan; 46(1):e38-e39. PubMed ID: 32956108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cavernosal Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT.
    Nguyen BD
    Clin Nucl Med; 2020 Oct; 45(10):e449-e450. PubMed ID: 32520500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligometastatic recurrent prostate cancer detects by fluorine-18-choline positron emission tomography/computed tomography in patients with prostate-specific antigen levels of up to 5 ng/ml.
    Evangelista L; Cuppari L; Guttilla A; Gardi M; Agostini A; Ruggera L; Basso U; Saladini G
    Nucl Med Commun; 2018 Mar; 39(3):260-267. PubMed ID: 29381584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Pietrzak AK; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Urol J; 2018 Sep; 15(5):242-247. PubMed ID: 29681049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer.
    Zattoni F; Agostini E; Cattaneo F; Maruzzo M; Basso U; Zattoni F; Evangelista L
    Clin Imaging; 2017; 43():110-116. PubMed ID: 28278446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 18F-choline PET/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics.
    Beheshti M; Haim S; Zakavi R; Steinmair M; Waldenberger P; Kunit T; Nader M; Langsteger W; Loidl W
    J Nucl Med; 2013 Jun; 54(6):833-40. PubMed ID: 23559588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
    Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
    BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-Head Comparison of 18F-Prostate-Specific Membrane Antigen-1007 and 18F-Fluorocholine PET/CT in Biochemically Relapsed Prostate Cancer.
    Witkowska-Patena E; Giżewska A; Dziuk M; Miśko J; Budzyńska A; Walęcka-Mazur A
    Clin Nucl Med; 2019 Dec; 44(12):e629-e633. PubMed ID: 31689286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Fluorocholine PET/CT Complementing the Role of Dynamic Contrast-Enhanced MRI for Providing Comprehensive Diagnostic Workup in Prostate Cancer Patients With Suspected Relapse Following Radical Prostatectomy.
    Vadi SK; Singh B; Basher RK; Watts A; Sood AK; Lal A; Kakkar N; Singh SK
    Clin Nucl Med; 2017 Aug; 42(8):e355-e361. PubMed ID: 28525448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition with (11)C-choline and (18)F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.
    von Eyben FE; Kairemo K
    Ann Nucl Med; 2016 Jul; 30(6):385-92. PubMed ID: 27173771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.
    Beheshti M; Vali R; Waldenberger P; Fitz F; Nader M; Loidl W; Broinger G; Stoiber F; Foglman I; Langsteger W
    Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1766-74. PubMed ID: 18465129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy.
    Vadi SK; Kumar R; Mittal BR; Parihar AS; Singh SK
    Clin Nucl Med; 2018 Apr; 43(4):276-278. PubMed ID: 29465493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage extended field or involved field nodal irradiation in
    Lépinoy A; Silva YE; Martin E; Bertaut A; Quivrin M; Aubignac L; Cochet A; Créhange G
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):40-48. PubMed ID: 30267117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
    Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
    J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How we read FCH-PET/CT for prostate cancer.
    Beauregard JM; Beaulieu A
    Cancer Imaging; 2016 Dec; 16(1):41. PubMed ID: 27923396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penile metastases from bladder and prostate cancer detected by PET/CT: a report of 3 cases and a review of literature.
    Spinapolice EG; Fuccio C; Rubino B; Palumbo R; Mensi M; Scopesi L; Trifirò G; Ivaldi GB
    Clin Genitourin Cancer; 2014 Aug; 12(4):e155-9. PubMed ID: 24787969
    [No Abstract]   [Full Text] [Related]  

  • 19. 18F-Fluorocholine PET/CT Finding of a Vertebral Hemangioma.
    Savelli G; Perotti V; Rosso E; Pizzocaro C; Magnaldi S
    Clin Nucl Med; 2016 Aug; 41(8):e390-1. PubMed ID: 27124683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic Metastases From Prostatic Adenocarcinoma Without Elevated 18F-Choline Activity.
    Dejust S; Messaoud L; Jallerat P; Marical V; Morland D
    Clin Nucl Med; 2018 Oct; 43(10):780-781. PubMed ID: 30153155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.